ArticleInternational journal of environmental research and public health2018
Depression Negatively Impacts Survival of Patients with Metastatic Prostate Cancer.
Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Depression increases cancer mortality by 23-83%: a meta-analysis of 65 studies across five major cancer types.GeroScience · 2026Pooled it
- Major Depression and Survival in People With Cancer.Psychosomatic medicine · 2021Pooled it
- Comparative Effectiveness of Psychosocial Protective Factors for Prostate Cancer Survivorship - A UK Biobank Study.Psycho-oncology · 2025Article
- The correlation between anger/agitation and other factors including spousal care in home-dwelling older adults with advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Mortality Risks Associated with Depression in Men with Prostate Cancer.European urology oncology · 2024Article
- Antidepressant medication use and prostate cancer recurrence in men with depressive disorders.Cancer causes & control : CCC · 2022Article
- Social Support Mediates the Relationship between Body Image Distress and Depressive Symptoms in Prostate Cancer Patients.International journal of environmental research and public health · 2022Article
- Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.The oncologist · 2022Article
- Dietary Fat and Prostate Cancer Relationship Using Trimmed Regression Under Uncertainty.Frontiers in nutrition · 2022Article
- Breaking the patientification process - through co-creation of care, using old arctic survival knowledge.International journal of qualitative studies on health and well-being · 2021Article
- Post-Treatment Adverse Health Correlates among Prostate Cancer Survivors in a Sample of Men Residing in Atlantic Canada.Current oncology (Toronto, Ont.) · 2021Article
- Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer.Cancers · 2021Review
- Psychosocial Stress and Age Influence Depression and Anxiety-Related Behavior, Drive Tumor Inflammatory Cytokines and Accelerate Prostate Cancer Growth in Mice.Frontiers in oncology · 2021Article
- Retrospective Analyses of Psychological Distress and Defense Style Among Cancer Patients.Clinical neuropsychiatry · 2020Article
- Unlocking the Mystery of the Therapeutic Effects of Chinese Medicine on Cancer.Frontiers in pharmacology · 2020Article
- Spirit-Quieting Traditional Chinese Medicine may Improve Survival in Prostate Cancer Patients with Depression.Journal of clinical medicine · 2019Article
- The prevalence of depression and anxiety in patients with metastatic disease to the spine.Journal of craniovertebral junction & spineArticle
- Mood disorder and cancer onset: evidence from a population-based sample of Australian women.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of depression in patients with cancer is high, especially for patients with advanced cancer. In this study, we evaluated the prevalence of depression in prostate cancer patients in Taiwan and the association between depression and mortality in prostate cancer. This study included 1101 newly diagnosed patients with prostate cancer. We tracked the medical information of these patients from diagnosis until the end of 2012. Patients were divided into two groups according to presence or absence of depression diagnosis, and were further divided into three stages by initial treatments: localized or locally advanced, metastatic, and castration-resistant prostate cancer. Of 1101 participants, 267 (24.3%) had depression. By the end of the follow-up period (M = 8.30 ± 3.12 years), 77 (28.8%) patients in the depression group and 194 (23.3%) in the non-depressed group died. Depression was associated with higher mortality risk, (aHR 1.37; 95% CI [ 1.04⁻1.80];
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.